All In MedTech

Device Trial Radar · NCT04670536

The Degen Study: Post-market Clinical Follow-up on the PASS LP, PASS Degen and PASS Tulip Systems (PASS DEGEN)

The Degen Study: Post-market Clinical Follow-up on the PASS LP, PASS Degen and PASS Tulip Systems.

Last checked: Nov 20, 2026Latest source record: May 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

77

Actual

Start

May 17, 2018

Primary completion

May 22, 2024

Study completion May 22, 2024

Sponsor

Lead sponsor
Medicrea InternationalNot on our public-company list
Sponsor type
Industry
First posted
Dec 17, 2020

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this post-market clinical study is to evaluate the long-term safety and efficacy of the MEDICREA's systems PASS LP, PASS DEGEN, and PASS Tulip PRIME to treat degenerative diseases. This study is supporting the clinical evaluation report. From the standard-of-care perspective, the results of The Degen study are expected to contribute to a better understanding of expected safety and clinical outcomes from a short (intra- and peri-operative) to a medium-term follow-up (post-operatively).

Conditions

  • Thoracolumbar Disc Degeneration
  • Thoracolumbar Spondylolisthesis
  • Spinal Deformity
  • Spinal Degeneration

Interventions

  • PASS LP implantsDevice

    Thoraco lumbar arthrodesis

  • PASS DEGENDevice

    Thoraco lumbar arthrodesis

  • PASS TULIP PRIMEDevice

    Thoraco lumbar arthrodesis

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participant Who Achieved Their Fusion at 24 MonthsTime frame: At 24months

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Clinique du Dos Bordeaux - Terrefort

    Bruges, France

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.